Geri Spollett

Bio

Geralyn R. Spollett, MSN, ANP-CS, CDE is President, Health Care & Education of the American Diabetes Association, the nation's largest voluntary health organization leading the fight to Stop Diabetes®. She is an adult nurse practitioner and Associate Director of Yale Diabetes Center, affiliated with the Yale School of Medicine Faculty Practice. She also serves on the Advisory Board of Aventis Pharmaceuticals and Eli Lilly Company.

Spollett has been an American Diabetes Association volunteer for more than 15 years and has served on the Programs and Professional Practice Committees, a previous term on the National Board of Directors, and on her local Community Leadership Board. She has also served as Chair of the National Certification Board for Diabetes Educators.  She is serving as Editor for the Educator’s Corner of Practical Diabetology and has served as an Associate Editor of Diabetes Spectrum and The Diabetes Educator.  She was an Associate Editor for the American Diabetes Association book, The Complete Nurses Guide to Diabetes Care.  She also received the American Diabetes Association Educator Award in 2006.

Spollett has won awards for excellence in clinical practice, nursing and teaching. During her 10 years at the Yale School of Nursing, she taught in the diabetes care concentration, conducted research in type 2 diabetes in black women, and lectured nationally and internationally on diabetes management from a nurse practitioner perspective. She has written more than 40 articles and book chapters largely focusing on the care and management of people with diabetes and been a speaker at numerous professional education conferences in Connecticut.

She earned her Bachelor of Science in nursing from Fairfield University in Fairfield, CT, and her Master of Science with distinction in primary care from Boston College in Chestnut Hill, MA.

Specialties:

  • endocrinology, diabetes & metabolism

Affiliation:

  • MSN, ANP-CS, CDE, President, Health Care & Education, American Diabetes Association

Location:

Group Memberships:

Activity

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, May 10 (HealthDay News) -- For people with celiac disease, an accurate diagnosis and proper diet are essential for good health, experts say.

    Celiac disease is an intolerance to the protein gluten, which is found in wheat, barley and rye. When people with celiac disease eat gluten-...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, April 25 (HealthDay News) -- A hormone that could lead to more effective diabetes treatment has been identified by researchers.

    The hormone, called betatrophin, causes mice to produce insulin-secreting pancreatic beta cells at up to 30 times the normal rate. But it only produces...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, April 25 (HealthDay News) -- Drinking just one 12-ounce sugar-sweetened soft drink a day can increase the risk of developing type 2 diabetes by up to 22 percent, a European study contends.

    The finding is based on an analysis of data collected from more than 28,000 people in Denm...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, April 12 (HealthDay News) -- Researchers have pinpointed a genetic mutation that is strongly associated with an increased risk of death in people with thyroid cancer.

    The investigators followed more than 1,800 patients after their initial treatment for papillary thyroid cancer, wh...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    MONDAY, April 1 (HealthDay News) -- Invokana (canaglifozin) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes, which affects about 24 million Americans.

    The drug is among a new class of medications called sodium-glucose co-transporter 2 inhibitors. It wor...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    TUESDAY, March 26 (HealthDay News) -- A simple breath test may be able to tell if you are overweight or will be in the future, a new study suggests.

    According to the findings, results from a standard breath test used to assess bacterial overgrowth in the gut can also tell doctors if you h...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, March 15 (HealthDay News) -- People who have type 1 diabetes are more likely than others to develop an autoimmune thyroid condition.

    Though estimates vary, the rate of thyroid disease -- either under- or overactive thyroid -- may be as high as 30 percent in people with type 1 dia...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, March 15 (HealthDay News) -- Jet Landis was only 4 years old when she was diagnosed with type 1 diabetes in 1992. Even though she was so young, she can still recall the extreme thirst she felt because of diabetes.

    Landis was lucky, though, because her mother was a nurse and recog...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    WEDNESDAY, March 6 (HealthDay News) -- The total cost of diabetes in the United States jumped from $174 billion in 2007 to $245 billion in 2012, a new report shows.

    Last year's total cost included $176 billion in direct medical costs -- such as hospital and emergency care, medications an...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    TUESDAY, March 5 (HealthDay News) -- A new bioengineered, miniature organ dubbed the BioHub might one day offer people with type 1 diabetes freedom from their disease.

    In its final stages, the BioHub would mimic a pancreas and act as a home for transplanted islet cells, providing them w...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    THURSDAY, Feb. 28 (HealthDay News) -- Could sofas and chairs be bad for your health? New research suggests that as time spent sitting goes up, so does a person's odds for type 2 diabetes.

    Telling people to avoid sitting might even be more effective in staving off diabetes than exhorting ...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    WEDNESDAY, Feb. 20 (HealthDay News) -- A staggering one in eight Americans has been diagnosed with type 2 diabetes, a new Harris Interactive/HealthDay poll suggests.

    And more than one third of those polled have been diagnosed with diabetes or have a parent, sibling, spouse or child...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, Feb. 15 (HealthDay News) -- A couple of decades ago, only 2 percent of people with any type of diabetes met or exceeded the three measures of good diabetes management. By 2010, that number had risen to 19 percent, according to new government research.

    These measures of good diab...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    FRIDAY, Jan. 25 (HealthDay News) -- The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.

    All three drugs contain a new active ingredient, alogliptin, either alone or in combination with other, previously approved medicatio...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology, Diabetes & Metabolism:

    MONDAY, Jan. 28 (HealthDay News) -- Three new related drugs designed to improve blood sugar control in people with type 2 diabetes have been approved by the U.S. Food and Drug Administration.

    All three drugs contain a new active ingredient, alogliptin (brand named Nesina), either by itsel...Full Article